{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T12:57:33Z","timestamp":1774097853179,"version":"3.50.1"},"publisher-location":"New York, NY","reference-count":19,"publisher":"Springer New York","isbn-type":[{"value":"9781493933853","type":"print"},{"value":"9781493933877","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-1-4939-3387-7_10","type":"book-chapter","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T11:08:16Z","timestamp":1460632096000},"page":"207-220","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Application of Droplet Digital PCR to Validate Rift Valley Fever Vaccines"],"prefix":"10.1007","author":[{"given":"Hoai J.","family":"Ly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nandadeva","family":"Lokugamage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Ikegami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,14]]},"reference":[{"key":"10_CR1","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1099\/0022-1317-66-10-2271","volume":"66","author":"H Caplen","year":"1985","unstructured":"Caplen H, Peters CJ, Bishop DH (1985) Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development. J Gen Virol 66:2271\u20132277","journal-title":"J Gen Virol"},{"key":"10_CR2","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/0035-9203(79)90004-X","volume":"73","author":"JM Meegan","year":"1979","unstructured":"Meegan JM (1979) The Rift Valley fever epizootic in Egypt 1977-78. 1. Description of the epizootic and virological studies. Trans R Soc Trop Med Hyg 73:618\u2013623","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10_CR3","doi-asserted-by":"publisher","first-page":"13566","DOI":"10.1128\/JVI.02081-12","volume":"86","author":"N Lokugamage","year":"2012","unstructured":"Lokugamage N, Freiberg AN, Morrill JC, Ikegami T (2012) Genetic subpopulations of Rift Valley fever ZH548, MP-12 and recombinant MP-12 strains. J Virol 86:13566\u201313575","journal-title":"J Virol"},{"key":"10_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0264-410X(91)90314-V","volume":"9","author":"JC Morrill","year":"1991","unstructured":"Morrill JC, Carpenter L, Taylor D, Ramsburg HH, Quance J et al (1991) Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep. Vaccine 9:35\u201341","journal-title":"Vaccine"},{"key":"10_CR5","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.2460\/ajvr.1987.48.07.1042","volume":"48","author":"JC Morrill","year":"1987","unstructured":"Morrill JC, Jennings GB, Caplen H, Turell MJ, Johnson AJ et al (1987) Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes. Am J Vet Res 48:1042\u20131047","journal-title":"Am J Vet Res"},{"key":"10_CR6","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2460\/ajvr.1997.58.10.1110","volume":"58","author":"JC Morrill","year":"1997","unstructured":"Morrill JC, Mebus CA, Peters CJ (1997) Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids. Am J Vet Res 58:1110\u20131114","journal-title":"Am J Vet Res"},{"key":"10_CR7","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2460\/ajvr.1997.58.10.1104","volume":"58","author":"JC Morrill","year":"1997","unstructured":"Morrill JC, Mebus CA, Peters CJ (1997) Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle. Am J Vet Res 58:1104\u20131109","journal-title":"Am J Vet Res"},{"key":"10_CR8","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1016\/S0264-410X(03)00131-2","volume":"21","author":"JC Morrill","year":"2003","unstructured":"Morrill JC, Peters CJ (2003) Pathogenicity and neurovirulence of a mutagen-attenuated Rift Valley fever vaccine in rhesus monkeys. Vaccine 21:2994\u20133002","journal-title":"Vaccine"},{"key":"10_CR9","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/infdis\/jir354","volume":"204","author":"JC Morrill","year":"2011","unstructured":"Morrill JC, Peters CJ (2011) Mucosal immunization of rhesus macaques with Rift Valley Fever MP-12 vaccine. J Infect Dis 204:617\u2013625","journal-title":"J Infect Dis"},{"key":"10_CR10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/infdis\/jir249","volume":"204","author":"JC Morrill","year":"2011","unstructured":"Morrill JC, Peters CJ (2011) Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent Rift Valley fever virus. J Infect Dis 204:229\u2013236","journal-title":"J Infect Dis"},{"key":"10_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-1-4939-0733-5_4","volume":"1160","author":"F Bizouarn","year":"2014","unstructured":"Bizouarn F (2014) Introduction to digital PCR. Methods Mol Biol 1160:27\u201341","journal-title":"Methods Mol Biol"},{"key":"10_CR12","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1021\/ac202578x","volume":"84","author":"LB Pinheiro","year":"2012","unstructured":"Pinheiro LB, Coleman VA, Hindson CM, Herrmann J, Hindson BJ et al (2012) Evaluation of a droplet digital polymerase chain reaction format for DNA copy number quantification. Anal Chem 84:1003\u20131011","journal-title":"Anal Chem"},{"key":"10_CR13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ab.2009.01.003","volume":"387","author":"R Aranda","year":"2009","unstructured":"Aranda R, Dineen SM, Craig RL, Guerrieri RA, Robertson JM (2009) Comparison and evaluation of RNA quantification methods using viral, prokaryotic, and eukaryotic RNA over a 10(4) concentration range. Anal Biochem 387:122\u2013127","journal-title":"Anal Biochem"},{"key":"10_CR14","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1101\/gr.4.6.357","volume":"4","author":"KJ Livak","year":"1995","unstructured":"Livak KJ, Flood SJ, Marmaro J, Giusti W, Deetz K (1995) Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization. PCR Methods Appl 4:357\u2013362","journal-title":"PCR Methods Appl"},{"key":"10_CR15","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1101\/gr.6.10.986","volume":"6","author":"CA Heid","year":"1996","unstructured":"Heid CA, Stevens J, Livak KJ, Williams PM (1996) Real time quantitative PCR. Genome Res 6:986\u2013994","journal-title":"Genome Res"},{"key":"10_CR16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.virol.2006.03.018","volume":"351","author":"N Gauliard","year":"2006","unstructured":"Gauliard N, Billecocq A, Flick R, Bouloy M (2006) Rift Valley fever virus noncoding regions of L, M and S segments regulate RNA synthesis. Virology 351:170\u2013179","journal-title":"Virology"},{"key":"10_CR17","unstructured":"So A, Heredia N, Troupe C (2012) Detection of rare mutant alleles within a background of wild-type sequences using the QX100 droplet digital PCR system. Bio-Rad Bulletin 6260"},{"key":"10_CR18","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1093\/nar\/gks596","volume":"40","author":"A Untergasser","year":"2012","unstructured":"Untergasser A, Cutcutache I, Koressaar T, Ye J, Faircloth BC et al (2012) Primer3--new capabilities and interfaces. Nucleic Acids Res 40:e115","journal-title":"Nucleic Acids Res"},{"key":"10_CR19","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1099\/vir.0.051250-0","volume":"94","author":"SV Indran","year":"2013","unstructured":"Indran SV, Lihoradova OA, Phoenix I, Lokugamage N, Kalveram B et al (2013) Rift Valley fever virus MP-12 vaccine encoding Toscana virus NSs retains neuroinvasiveness in mice. J Gen Virol 94:1441\u20131450","journal-title":"J Gen Virol"}],"container-title":["Methods in Molecular Biology","Vaccine Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-3387-7_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T17:59:55Z","timestamp":1748887195000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-3387-7_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9781493933853","9781493933877"],"references-count":19,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-3387-7_10","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]},"assertion":[{"value":"14 April 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}